| Green Mountain Primary Care Plc | |
|
102a Court St Ste A Middlebury VT 05753-1455 | |
| (802) 382-0849 | |
| (802) 382-0144 |
| Full Name | Green Mountain Primary Care Plc |
|---|---|
| Speciality | Family Medicine |
| Location | 102a Court St Ste A, Middlebury, Vermont |
| Authorized Official Name and Position | Laura Weylman (PHYSICIAN) |
| Authorized Official Contact | 8023820849 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Green Mountain Primary Care Plc 1108 Quarry Rd Middlebury VT 05753-8951 Ph: (802) 349-3015 | Green Mountain Primary Care Plc 102a Court St Ste A Middlebury VT 05753-1455 Ph: (802) 382-0849 |
| NPI Number | 1265901938 |
|---|---|
| Provider Enumeration Date | 11/25/2018 |
| Last Update Date | 09/19/2021 |
| Medicare PECOS PAC ID | 5496090920 |
|---|---|
| Medicare Enrollment ID | O20190102002198 |
News Archive
GOP lawmakers may grill President Barack Obama's latest Supreme Court nominee, Elana Kagan, over her views on the recent health overhaul law, Modern Healthcare reports.
A team of researchers at The New York Stem Cell Foundation Research Institute led by Scott Noggle, PhD, Director of the NYSCF Laboratory and the NYSCF - Charles Evans Senior Research Fellow for Alzheimer's Disease, and Michael W. Nestor, PhD, a NYSCF Postdoctoral Research Fellow, has developed a technique to produce three-dimensional cultures of induced pluripotent stem cells called embryoid bodies, amenable to live cell imaging and to electrical activity measurement.
New clinical trial results for heart transplant patients will be released at the upcoming International Society for Heart and Lung Transplantation (ISHLT) 27th Annual Meeting and Scientific Sessions at the Hilton San Francisco, April 25-28, 2007.
Castrate-refractory prostate cancer (CRPC), which is characterized by tumor progression despite castrate levels of testosterone, develops in many prostate cancer patients treated with androgen-deprivation therapy. Standardized guidelines for treatment of CRPC are lacking and healthcare professionals must consider several factors, including serum markers, patient age and pre-existing comorbidities when choosing between second-line hormonal therapy and chemotherapy for treatment of CRPC.
Anorexic patients drastically reduce food intake and are often not capable of changing their behavior. This can lead to life-threatening weight loss. Using MRI technology, scientists at Heidelberg University Hospital have discovered for the first time processes in brain metabolism that explain this disturbed eating behavior.
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265901938 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
| Provider Name | Laura E Weylman |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1932294295 PECOS PAC ID: 6901861830 Enrollment ID: I20081209000626 |
News Archive
GOP lawmakers may grill President Barack Obama's latest Supreme Court nominee, Elana Kagan, over her views on the recent health overhaul law, Modern Healthcare reports.
A team of researchers at The New York Stem Cell Foundation Research Institute led by Scott Noggle, PhD, Director of the NYSCF Laboratory and the NYSCF - Charles Evans Senior Research Fellow for Alzheimer's Disease, and Michael W. Nestor, PhD, a NYSCF Postdoctoral Research Fellow, has developed a technique to produce three-dimensional cultures of induced pluripotent stem cells called embryoid bodies, amenable to live cell imaging and to electrical activity measurement.
New clinical trial results for heart transplant patients will be released at the upcoming International Society for Heart and Lung Transplantation (ISHLT) 27th Annual Meeting and Scientific Sessions at the Hilton San Francisco, April 25-28, 2007.
Castrate-refractory prostate cancer (CRPC), which is characterized by tumor progression despite castrate levels of testosterone, develops in many prostate cancer patients treated with androgen-deprivation therapy. Standardized guidelines for treatment of CRPC are lacking and healthcare professionals must consider several factors, including serum markers, patient age and pre-existing comorbidities when choosing between second-line hormonal therapy and chemotherapy for treatment of CRPC.
Anorexic patients drastically reduce food intake and are often not capable of changing their behavior. This can lead to life-threatening weight loss. Using MRI technology, scientists at Heidelberg University Hospital have discovered for the first time processes in brain metabolism that explain this disturbed eating behavior.
› Verified 2 days ago
| Provider Name | Ania W Mortier |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1487052593 PECOS PAC ID: 4082932892 Enrollment ID: I20150407001569 |
News Archive
GOP lawmakers may grill President Barack Obama's latest Supreme Court nominee, Elana Kagan, over her views on the recent health overhaul law, Modern Healthcare reports.
A team of researchers at The New York Stem Cell Foundation Research Institute led by Scott Noggle, PhD, Director of the NYSCF Laboratory and the NYSCF - Charles Evans Senior Research Fellow for Alzheimer's Disease, and Michael W. Nestor, PhD, a NYSCF Postdoctoral Research Fellow, has developed a technique to produce three-dimensional cultures of induced pluripotent stem cells called embryoid bodies, amenable to live cell imaging and to electrical activity measurement.
New clinical trial results for heart transplant patients will be released at the upcoming International Society for Heart and Lung Transplantation (ISHLT) 27th Annual Meeting and Scientific Sessions at the Hilton San Francisco, April 25-28, 2007.
Castrate-refractory prostate cancer (CRPC), which is characterized by tumor progression despite castrate levels of testosterone, develops in many prostate cancer patients treated with androgen-deprivation therapy. Standardized guidelines for treatment of CRPC are lacking and healthcare professionals must consider several factors, including serum markers, patient age and pre-existing comorbidities when choosing between second-line hormonal therapy and chemotherapy for treatment of CRPC.
Anorexic patients drastically reduce food intake and are often not capable of changing their behavior. This can lead to life-threatening weight loss. Using MRI technology, scientists at Heidelberg University Hospital have discovered for the first time processes in brain metabolism that explain this disturbed eating behavior.
› Verified 2 days ago
News Archive
GOP lawmakers may grill President Barack Obama's latest Supreme Court nominee, Elana Kagan, over her views on the recent health overhaul law, Modern Healthcare reports.
A team of researchers at The New York Stem Cell Foundation Research Institute led by Scott Noggle, PhD, Director of the NYSCF Laboratory and the NYSCF - Charles Evans Senior Research Fellow for Alzheimer's Disease, and Michael W. Nestor, PhD, a NYSCF Postdoctoral Research Fellow, has developed a technique to produce three-dimensional cultures of induced pluripotent stem cells called embryoid bodies, amenable to live cell imaging and to electrical activity measurement.
New clinical trial results for heart transplant patients will be released at the upcoming International Society for Heart and Lung Transplantation (ISHLT) 27th Annual Meeting and Scientific Sessions at the Hilton San Francisco, April 25-28, 2007.
Castrate-refractory prostate cancer (CRPC), which is characterized by tumor progression despite castrate levels of testosterone, develops in many prostate cancer patients treated with androgen-deprivation therapy. Standardized guidelines for treatment of CRPC are lacking and healthcare professionals must consider several factors, including serum markers, patient age and pre-existing comorbidities when choosing between second-line hormonal therapy and chemotherapy for treatment of CRPC.
Anorexic patients drastically reduce food intake and are often not capable of changing their behavior. This can lead to life-threatening weight loss. Using MRI technology, scientists at Heidelberg University Hospital have discovered for the first time processes in brain metabolism that explain this disturbed eating behavior.
› Verified 2 days ago
Porter Hospital Dba Cedar Ledge Family Practice Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 99 Court St, Cedar Lodge Family Practice, Middlebury, VT 05753 Phone: 802-388-7185 Fax: 802-388-3445 | |
Five-town Health Alliance, Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 56 College St, Middlebury, VT 05753 Phone: 802-453-5028 | |
Porter Hospital Dba Addison Family Health Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 28 Catamount Drive, Addison Family Health, Middlebury, VT 05753 Phone: 802-388-7185 Fax: 802-388-3445 | |
Porter Hospital Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 115 Porter Drive, Porter Hospital, Middlebury, VT 05753 Phone: 802-388-5607 Fax: 802-388-5654 | |
Porter Hospital Inc Dba Porter Internal Medicine Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 116 Porter Drive, Porter Internal Medicine, Middlebury, VT 05753 Phone: 802-388-8805 Fax: 802-388-5619 | |
Village Health, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 5 Park St Ste 3a, Middlebury, VT 05753 Phone: 802-922-6538 |